Tags

Type your tag names separated by a space and hit enter

Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations.
Acc Chem Res. 2015 May 19; 48(5):1308-18.AC

Abstract

Transition-metal catalyzed C-H functionalizations became a complementary and efficient bond-forming strategy over the past decade. In this respect, Cp*Rh(III) complexes have emerged as powerful catalysts for a broad spectrum of reactions giving access to synthetically versatile building blocks. Despite their high potential, the corresponding catalytic enantioselective transformations largely lag behind. The targeted transformations require all the remaining three coordination sites of the central rhodium atom of the catalyst. In consequence, the chiral information on a competent catalyst can only by stored in the cyclopentadienyl unit. The lack of suitable enabling chiral cyclopentadienyl (Cp(x)) ligands is the key hurdle preventing the development of such asymmetric versions. In this respect, an efficient set of chiral Cp(x) ligands useable with a broad variety of different transition-metals can unlock substantial application potential. This Account provides a description of our developments of two complementary classes of C2-symmetric Cp(x) derivatives. We have introduced a side- and back-wall concept to enforce chirality transfer onto the central metal atom. The first generation consists of a fused cyclohexane unit having pseudo axial methyl groups as chiral selectors and a rigidifying acetal moiety. The second ligand generation derives from an atrop-chiral biaryl-backbone and which possesses adjustable substituents at its 3,3'-positions. Both ligand families can be modulated in their respective steric bulk to adjust for the specific needs of the targeted application. The cyclopentadienes can be metalated under standard conditions. The corresponding chiral rhodium(I) ethylene complexes are relatively air and moisture and represent storable stable precatalysts for the targeted asymmetric Rh(III)-catalyzed C-H functionalizations. These complexes are then conveniently oxidized in situ by dibenzoyl peroxide to give the reactive Cp(x)Rh(III)(OBz)2 species. For instance, this catalyst is used for directed C-H activations of aryl hydroxamates and the subsequent enantioselective trapping with olefins, providing dihydroisoquinolones in very high enantioselectivities. In addition, we have established highly selective intramolecular trapping reactions with tethered higher substituted alkenes giving dihydrobenzofurans with quaternary stereogenic centers. Concerning intermolecular reactions, allene coupling partners allow for an enantioselective hydroarylation yielding substituted allylated compounds. A trapping process of the cyclometalated intermediate with diazo reactants enables the enantioselective construction of isoindolinones. Moreover, the catalysts can be used for the construction of atropchiral biaryl motives using a dehydrogenative Heck-type reaction. The development of flexibly adjustable chiral Cp(x) ligands is described in this Account showcasing their applicability for a variety of Rh(III) catalyzed C-H functionalization reactions. These Cp(x) derivatives hold promise as powerful steering ligands for further transition-metals used in asymmetric catalysis.

Authors+Show Affiliations

Laboratory of Asymmetric Catalysis and Synthesis, Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), SB-ISIC, BCH4305, 1015 Lausanne, Switzerland.Laboratory of Asymmetric Catalysis and Synthesis, Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), SB-ISIC, BCH4305, 1015 Lausanne, Switzerland.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25884306

Citation

Ye, Baihua, and Nicolai Cramer. "Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations." Accounts of Chemical Research, vol. 48, no. 5, 2015, pp. 1308-18.
Ye B, Cramer N. Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations. Acc Chem Res. 2015;48(5):1308-18.
Ye, B., & Cramer, N. (2015). Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations. Accounts of Chemical Research, 48(5), 1308-18. https://doi.org/10.1021/acs.accounts.5b00092
Ye B, Cramer N. Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations. Acc Chem Res. 2015 May 19;48(5):1308-18. PubMed PMID: 25884306.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chiral Cyclopentadienyls: Enabling Ligands for Asymmetric Rh(III)-Catalyzed C-H Functionalizations. AU - Ye,Baihua, AU - Cramer,Nicolai, Y1 - 2015/04/17/ PY - 2015/4/18/entrez PY - 2015/4/18/pubmed PY - 2016/3/29/medline SP - 1308 EP - 18 JF - Accounts of chemical research JO - Acc Chem Res VL - 48 IS - 5 N2 - Transition-metal catalyzed C-H functionalizations became a complementary and efficient bond-forming strategy over the past decade. In this respect, Cp*Rh(III) complexes have emerged as powerful catalysts for a broad spectrum of reactions giving access to synthetically versatile building blocks. Despite their high potential, the corresponding catalytic enantioselective transformations largely lag behind. The targeted transformations require all the remaining three coordination sites of the central rhodium atom of the catalyst. In consequence, the chiral information on a competent catalyst can only by stored in the cyclopentadienyl unit. The lack of suitable enabling chiral cyclopentadienyl (Cp(x)) ligands is the key hurdle preventing the development of such asymmetric versions. In this respect, an efficient set of chiral Cp(x) ligands useable with a broad variety of different transition-metals can unlock substantial application potential. This Account provides a description of our developments of two complementary classes of C2-symmetric Cp(x) derivatives. We have introduced a side- and back-wall concept to enforce chirality transfer onto the central metal atom. The first generation consists of a fused cyclohexane unit having pseudo axial methyl groups as chiral selectors and a rigidifying acetal moiety. The second ligand generation derives from an atrop-chiral biaryl-backbone and which possesses adjustable substituents at its 3,3'-positions. Both ligand families can be modulated in their respective steric bulk to adjust for the specific needs of the targeted application. The cyclopentadienes can be metalated under standard conditions. The corresponding chiral rhodium(I) ethylene complexes are relatively air and moisture and represent storable stable precatalysts for the targeted asymmetric Rh(III)-catalyzed C-H functionalizations. These complexes are then conveniently oxidized in situ by dibenzoyl peroxide to give the reactive Cp(x)Rh(III)(OBz)2 species. For instance, this catalyst is used for directed C-H activations of aryl hydroxamates and the subsequent enantioselective trapping with olefins, providing dihydroisoquinolones in very high enantioselectivities. In addition, we have established highly selective intramolecular trapping reactions with tethered higher substituted alkenes giving dihydrobenzofurans with quaternary stereogenic centers. Concerning intermolecular reactions, allene coupling partners allow for an enantioselective hydroarylation yielding substituted allylated compounds. A trapping process of the cyclometalated intermediate with diazo reactants enables the enantioselective construction of isoindolinones. Moreover, the catalysts can be used for the construction of atropchiral biaryl motives using a dehydrogenative Heck-type reaction. The development of flexibly adjustable chiral Cp(x) ligands is described in this Account showcasing their applicability for a variety of Rh(III) catalyzed C-H functionalization reactions. These Cp(x) derivatives hold promise as powerful steering ligands for further transition-metals used in asymmetric catalysis. SN - 1520-4898 UR - https://www.unboundmedicine.com/medline/citation/25884306/Chiral_Cyclopentadienyls:_Enabling_Ligands_for_Asymmetric_Rh_III__Catalyzed_C_H_Functionalizations_ DB - PRIME DP - Unbound Medicine ER -